Birchview Capital, LP Wave Life Sciences Ltd. Transaction History
Birchview Capital, LP
- $111 Million
- Q1 2025
A detailed history of Birchview Capital, LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Birchview Capital, LP holds 40,300 shares of WVE stock, worth $326,027. This represents 0.29% of its overall portfolio holdings.
Number of Shares
40,300
Previous 40,000
0.75%
Holding current value
$326,027
Previous $494,000
34.21%
% of portfolio
0.29%
Previous 0.42%
Shares
3 transactions
Others Institutions Holding WVE
# of Institutions
202Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$147 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$101 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$66.8 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$54.5 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$51.4 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $702M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...